Evidence map›Paper›PMID 18471802›Full record

ArticleBiological psychiatry2008

A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation.

Shiro Suda, Eri Segi-Nishida, Samuel S Newton, Ronald S Duman

Registry-linked trialAbstract read
In one paragraph

Article in Biological psychiatry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03638687 (Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers), which is not on this map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03638687 completednot on this mapstarted 2014, after this paper: background citation

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

TypeobservationalSponsorJohns Hopkins UniversityRan2014 to 2020Enrolled80ConditionsPost Partum Depression, Bipolar Disorder
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 159 citations in OpenAlex.

  1. Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shiro SudaDivision of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Connecticut 06508, USA.
Eri Segi-Nishida
Samuel S Newton
Ronald S Duman
Yale University · USConnecticut Mental Health Center · US

Funding

SCHIZOPHRENIAP01MH025642 · NIMH · YALE UNIVERSITY · PI DUMAN, RONALD S. · 1985 to 2006
$8.4M
Antidepressants: Signal Transduction and Gene ExpressionR37MH045481 · NIMH · YALE UNIVERSITY · PI DUMAN, RONALD S. · 2005 to 2014
$3.5M
ANTIDEPRESSANTS AND SIGNAL TRANSDUCTION IN BRAINR01MH045481 · NIMH · YALE UNIVERSITY · PI DUMAN, RONALD S. · 1995 to 2004
$1.3M
ANTIDEPRESSANTS: SIGNAL TRANSDUCTION AND GENE EXPRESSIONR29MH045481 · NIMH · YALE UNIVERSITY · PI DUMAN, RONALD S. · 1989 to 1993
–
NIMH NIH HHS 2 PO1 MH25642NIMH NIH HHS MH45481NIMH NIH HHS P01 MH025642NIMH NIH HHS R01 MH045481NIMH NIH HHS R37 MH045481
6 · The paper itself

Abstract

backgroundPostpartum depression (PPD) affects approximately 10% to 20% of women during the first 4 weeks of the postpartum period and is characterized by labile mood with prominent anxiety and irritability, insomnia, and depressive mood. During the postpartum period, elevated ovarian hormones abruptly decrease to the early follicular phase levels that are postulated to play a major role in triggering PPD. However, the underlying neurobiological mechanisms that contribute to PPD have not been determined.

methodsIn the present study, we examined the effect of ovarian steroids, administered at levels that occur during human pregnancy followed by rapid withdrawal to simulate postpartum conditions, on behavior and gene expression in the rat.

resultsThe results of behavioral testing reveal that the hormone-simulated postpartum treatment results in the development of a phenotype relevant to PPD, including vulnerability for helplessness, increased anxiety, and aggression. Real-time quantitative polymerase chain reaction (PCR) demonstrated transient regulation of several genes, including Ca(2+)/calmodulin-dependent protein kinase II (CAMKII), serotonin transporter (SERT), myocyte enhancer factor 2A (MEF2A), brain-derived neurotrophic factor (BDNF), gamma-aminobutyric acid type A receptor alpha 4 (GABAARA4), mothers against decapentaplegic homolog 4 (SMAD4), and aquaporin 4 (AQP4) that could underlie these behavioral effects.

conclusionsThese studies provide an improved understanding of the effects of withdrawal from high doses of ovarian hormones on behavior and gene expression changes in the brain that could contribute to the pathophysiology of PPD.

Indexed as

Depression, PostpartumAnalysis of VarianceAnimalsAquaporin 4Behavior, AnimalCalcium-Calmodulin-Dependent Protein Kinase Type 2Disease Models, AnimalEstradiolExploratory BehaviorFemaleGene Expression RegulationHelplessness, LearnedMaze LearningMEF2 Transcription FactorsMyogenic Regulatory FactorsNerve Tissue ProteinsAquaporin 4Calcium-Calmodulin-Dependent Protein Kinase Type 2EstradiolMEF2 Transcription FactorsMyogenic Regulatory FactorsNerve Tissue ProteinsReceptors, GABA-ASteroids

Identifiers

PMID18471802
PMCPMC3714803
OpenAlexW2012849493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.